Last $6.62 USD
Change Today +0.14 / 2.16%
Volume 83.9K
MDXG On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 10:52 AM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

mimedx group inc (MDXG) Snapshot

Open
$6.54
Previous Close
$6.48
Day High
$6.67
Day Low
$6.43
52 Week High
12/31/13 - $8.80
52 Week Low
09/4/13 - $1.81
Market Cap
699.4M
Average Volume 10 Days
539.0K
EPS TTM
$-0.03
Shares Outstanding
105.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MIMEDX GROUP INC (MDXG)

Related News

No related news articles were found.

mimedx group inc (MDXG) Related Businessweek News

No Related Businessweek News Found

mimedx group inc (MDXG) Details

MiMedx Group, Inc., together with its subsidiaries, designs, manufactures, and markets products and tissue processing services in the United States. The company’s products include patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies comprise AmnioFix and EpiFix, which are tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through the company’s donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. It processes the human amniotic membrane utilizing its proprietary PURION process to produce a safe and effective implant. The company also provides CollaFix, a medical device technology platform. It supplies amniotic tissue on OEM basis for application in the wound care, surgical, sports medicine, ophthalmic, and dental sectors of healthcare through direct sales force, independent sales representatives, and distributors, as well as through private label or OEM relationships. The company is headquartered in Marietta, Georgia.

222 Employees
Last Reported Date: 03/4/14

mimedx group inc (MDXG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $465.2K
President, Chief Operating Officer and Direct...
Total Annual Compensation: $385.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $268.3K
Vice President, General Counsel and Consultan...
Total Annual Compensation: $240.0K
Compensation as of Fiscal Year 2013.

mimedx group inc (MDXG) Key Developments

MiMedx Group, Inc. Increases Guidance for Second Quarter and Full Year of 2014

MiMedx Group, Inc. announced its revised guidance for the second quarter and full year of 2014. For the quarter, the company updated estimates are for second quarter of 2014 revenue to be in the range of $24 million to $25 million. On May 27, 2014, the company raised its lower end estimate and communicated its expectations for second quarter revenue to be in the range of $22.5 million to $23.5 million. At this time, the company narrowed its full year 2014 guidance from $100 million to $110 million to $105 million to $110 million based on the strength of the first half of the year.

MiMedx Group, Inc. Revised Earnings Guidance for the Second Quarter of 2014 and Full Year 2014

MiMedx Group, Inc. revised earnings guidance for the second quarter of 2014 and full year 2014. The company's updated estimates are for second quarter of 2014 revenue to be in the range of $22.5 million to $23.5 million. Previously, the company had published second quarter revenue estimates in the range of $21.5 million to $23.5 million. Updated full year 2014 revenue is now estimated by the company to be in the range of $100 million to $110 million. On March 24, 2014, the company raised original low end estimate for full year 2014 revenue from $90 million to $95 million.

MiMedx Group, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-03-2014 09:30 AM

MiMedx Group, Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-03-2014 09:30 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Michael J. Senken, Chief Financial Officer, Principal Accounting Officer and Vice President, Parker H. Petit, Chairman and Chief Executive Officer, William Charles Taylor, President, Chief Operating Officer and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDXG:US $6.62 USD +0.14

MDXG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Shire PLC 4,974 GBp +3.00
View Industry Companies
 

Industry Analysis

MDXG

Industry Average

Valuation MDXG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.4x
Price/Book 9.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 9.8x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIMEDX GROUP INC, please visit www.mimedx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.